These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 19393270)
1. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. Shen J; Wang Y; Ping Q; Xiao Y; Huang X J Control Release; 2009 Aug; 137(3):217-23. PubMed ID: 19393270 [TBL] [Abstract][Full Text] [Related]
2. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution. Shen J; Deng Y; Jin X; Ping Q; Su Z; Li L Int J Pharm; 2010 Dec; 402(1-2):248-53. PubMed ID: 20934499 [TBL] [Abstract][Full Text] [Related]
3. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003 [TBL] [Abstract][Full Text] [Related]
6. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497 [TBL] [Abstract][Full Text] [Related]
7. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa. Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery. Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416 [TBL] [Abstract][Full Text] [Related]
10. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin. Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323 [TBL] [Abstract][Full Text] [Related]
11. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
12. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome. Tan G; Li J; Song Y; Yu Y; Liu D; Pan W Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075 [TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Luo Q; Zhao J; Zhang X; Pan W Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778 [TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. Liu R; Liu Z; Zhang C; Zhang B J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401 [TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY; Fang CL; Liu CH; Su YH Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447 [TBL] [Abstract][Full Text] [Related]
18. Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles. Garcia-Fuentes M; Torres D; Martín-Pastor M; Alonso MJ Langmuir; 2004 Sep; 20(20):8839-45. PubMed ID: 15379515 [TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies. Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458 [TBL] [Abstract][Full Text] [Related]
20. PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake. Luan J; Yang X; Chu L; Xi Y; Zhai G J Colloid Interface Sci; 2014 Aug; 428():49-56. PubMed ID: 24910034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]